Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 15 tags : Positive save search
InflaRx Announces Positive Data from Phase II IXCHANGE Study with Vilobelimab in ANCA-associated Vasculitis (AAV)
Published: 2021-11-15 (Crawled : 15:00) - biospace.com/
IFRX | $1.4 -6.67% -7.14% 150K
|
Health Technology
|
| O: -1.97%
H: 3.94%
C: -10.42%
positive
Immutep Publishes AIPAC, TACTI-002 and TACTI-003 Trial Posters at SITC with Positive New Data for LAG-3 Therapy, Eftilagimod Alpha
Published: 2021-11-15 (Crawled : 15:00) - biospace.com/
IMMP | $2.33 -6.43% -6.87% 220K
|
Health Technology
|
| O: 0.47%
H: 1.16%
C: -0.93%
positive therapy trial
AnaptysBio Announces Positive Rosnilimab Healthy Volunteer Phase 1 Top-Line Data
Published: 2021-11-15 (Crawled : 14:00) - ir.anaptysbio.com
ANAB | $21.3 -6.21% -6.62% 270K
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
phase 1 positive topline phase 2 phase 3
Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A Therapeutic in Patients Undergoing Coronary Artery Bypass Grafting Surgery
Published: 2021-11-15 (Crawled : 14:00) - biospace.com/
MRNA S | $103.86 -1.22% -1.23% 2.2M
|
Health Technology
|
| O: 2.19%
H: 0.0%
C: 0.0%
phase 2 positive
Lear to Supply Advanced Connectivity and Vehicle Positioning Solutions to Global Electric Vehicle Manufacturer
Published: 2021-11-15 (Crawled : 13:30) - prnewswire.com
LEA | $132.34 -1.02% 0.0% 680K
|
Producer Manufacturing
|
| O: 4.36%
H: 1.44%
C: 1.39%
electric vehicle positive
SHARC Energy Files Record Breaking Revenue and First Cash Flow Positive Quarter
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
INTWF | $0.166 0% 2.3K
|
Producer Manufacturing
|
| O: -2.74%
H: 0.0%
C: -5.94%
energy positive
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
RCKT S | $24.01 -0.74% -0.75% 580K
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: -23.94%
disease phase 1 positive trial phase 2 phase 3 rp-a501 danon disease
2-THE-TOP Phase 2 Trial Reports Positive Top-Line Results in Newly Diagnosed Glioblastoma
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
NVCR | $12.72 -6.26% -6.68% 1.1M
|
Health Technology
|
| O: 3.0%
H: 0.39%
C: -3.17%
phase 2 positive results trial topline glioblastoma
Protagonist Therapeutics Announces Positive Phase 2a Data Supporting the Potential Use of Rusfertide as a First-in-Class Therapy in Hereditary Hemochromatosis
Published: 2021-11-15 (Crawled : 12:00) - prnewswire.com
PTGX | $26.59 -1.66% -1.69% 440K
|
Health Technology
|
| O: 4.69%
H: 0.0%
C: 0.0%
phase 2 potential positive therapy phase 2b
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.